Inspire Medical Systems (INSP) has released an update to notify the public and investors about a regulation fd disclosure.
In the upcoming months of February and March, the Company is set to engage with investors and analysts through a series of meetings, utilizing presentation materials that can be accessed on their Investor Relations website. It’s important to note that the information provided in these materials and reports is not considered officially filed under securities law regulations, nor is it integrated into any legal filings, unless explicitly stated.
For further insights into INSP stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
